SuperworthNEUROONE MEDICAL TECHNOLOGIES shares outstanding NMTC
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 8.7M
- On a year earlier
- +7.9%
- more shares
NEUROONE MEDICAL TECHNOLOGIES had 8.7M diluted shares outstanding on average in Q3 FY26, the quarter to Jun 30, 2026.
That is 7.9% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 8.3M | +68% |
| FY2024 | 5M | +34% |
| FY2023 | 3.7M | +37% |
| FY2022 | 2.7M | +35% |
| FY2021 | 2M | +68% |
| FY2020 | 1.2M | +58% |
| FY2019 | 749.3K | +43% |
| FY2018 | 522.9K | +20% |
| FY2017 | 436.9K | +55% |
| FY2016 | 281.8K | +0% |
| FY2015 | 281.8K | +0% |
| FY2014 | 281.8K | −25% |
| FY2013 | 376.3K | −0% |
| FY2012 | 376.6K | +37% |
| FY2011 | 275.8K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q3 FY26 | 8.7M | +8% | |
| Q2 FY26 | 8.5M | +64% | |
| Q1 FY26 | 8.4M | +63% | |
| Q4 FY25 | 8.3M | +68% | |
| Q3 FY25 | 8.1M | +78% | |
| Q2 FY25 | 5.2M | +20% | |
| Q1 FY25 | 5.1M | +29% | |
| Q4 FY24 | 5M | +34% | |
| Q3 FY24 | 4.6M | +56% | |
| Q2 FY24 | 4.3M | +58% | |
| Q1 FY24 | 4M | +48% | |
| Q4 FY23 | 3.7M | +37% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on NEUROONE MEDICAL TECHNOLOGIES
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.